Phosphorylated Ubiquitin as a Clinical Biomarker for Mitochondrial Damage in Neurodegenerative Diseases
Fabienne C. Fiesel(WinnMed), Wolfdieter Springer(WinnMed)
Cited by 0
Related Papers
Knockdown of transactive response DNA‐binding protein (TDP‐43) downregulates histone deacetylase 6
|The EMBO Journal|2009|228
Heterozygous PINK1 p.G411S increases risk of Parkinson’s disease via a dominant-negative mechanism
|Brain|2016|142
TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR
|Nucleic Acids Research|2011|107
Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent
|Brain Pathology|2023|41
The UFMylation pathway is impaired in Alzheimer’s disease
|Molecular Neurodegeneration|2024|14